Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
- PMID: 30243584
- PMCID: PMC6202443
- DOI: 10.1016/S1473-3099(18)30310-4
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Abstract
Background: Lower respiratory infections are a leading cause of morbidity and mortality around the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, provides an up-to-date analysis of the burden of lower respiratory infections in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 26 years and shows how the burden of lower respiratory infection has changed in people of all ages.
Methods: We used three separate modelling strategies for lower respiratory infections in GBD 2016: a Bayesian hierarchical ensemble modelling platform (Cause of Death Ensemble model), which uses vital registration, verbal autopsy data, and surveillance system data to predict mortality due to lower respiratory infections; a compartmental meta-regression tool (DisMod-MR), which uses scientific literature, population representative surveys, and health-care data to predict incidence, prevalence, and mortality; and modelling of counterfactual estimates of the population attributable fraction of lower respiratory infection episodes due to Streptococcus pneumoniae, Haemophilus influenzae type b, influenza, and respiratory syncytial virus. We calculated each modelled estimate for each age, sex, year, and location. We modelled the exposure level in a population for a given risk factor using DisMod-MR and a spatio-temporal Gaussian process regression, and assessed the effectiveness of targeted interventions for each risk factor in children younger than 5 years. We also did a decomposition analysis of the change in LRI deaths from 2000-16 using the risk factors associated with LRI in GBD 2016.
Findings: In 2016, lower respiratory infections caused 652 572 deaths (95% uncertainty interval [UI] 586 475-720 612) in children younger than 5 years (under-5s), 1 080 958 deaths (943 749-1 170 638) in adults older than 70 years, and 2 377 697 deaths (2 145 584-2 512 809) in people of all ages, worldwide. Streptococcus pneumoniae was the leading cause of lower respiratory infection morbidity and mortality globally, contributing to more deaths than all other aetiologies combined in 2016 (1 189 937 deaths, 95% UI 690 445-1 770 660). Childhood wasting remains the leading risk factor for lower respiratory infection mortality among children younger than 5 years, responsible for 61·4% of lower respiratory infection deaths in 2016 (95% UI 45·7-69·6). Interventions to improve wasting, household air pollution, ambient particulate matter pollution, and expanded antibiotic use could avert one under-5 death due to lower respiratory infection for every 4000 children treated in the countries with the highest lower respiratory infection burden.
Interpretation: Our findings show substantial progress in the reduction of lower respiratory infection burden, but this progress has not been equal across locations, has been driven by decreases in several primary risk factors, and might require more effort among elderly adults. By highlighting regions and populations with the highest burden, and the risk factors that could have the greatest effect, funders, policy makers, and programme implementers can more effectively reduce lower respiratory infections among the world's most susceptible populations.
Funding: Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures








Comment in
-
The global burden of lower respiratory infections: making progress, but we need to do better.Lancet Infect Dis. 2018 Nov;18(11):1162-1163. doi: 10.1016/S1473-3099(18)30407-9. Epub 2018 Sep 19. Lancet Infect Dis. 2018. PMID: 30243585 No abstract available.
Similar articles
-
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Infect Dis. 2018 Nov;18(11):1211-1228. doi: 10.1016/S1473-3099(18)30362-1. Epub 2018 Sep 19. Lancet Infect Dis. 2018. PMID: 30243583 Free PMC article.
-
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Infect Dis. 2017 Nov;17(11):1133-1161. doi: 10.1016/S1473-3099(17)30396-1. Epub 2017 Aug 23. Lancet Infect Dis. 2017. PMID: 28843578 Free PMC article.
-
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15. Lancet Infect Dis. 2024. PMID: 38636536 Free PMC article.
-
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.Lancet Infect Dis. 2022 Nov;22(11):1626-1647. doi: 10.1016/S1473-3099(22)00510-2. Epub 2022 Aug 11. Lancet Infect Dis. 2022. PMID: 35964613 Free PMC article.
-
The trends of mortality, aetiologies and risk factors of lower respiratory infections in Saudi Arabia from 1990 to 2021: results from the global burden of disease study 2021.J Health Popul Nutr. 2025 May 24;44(1):172. doi: 10.1186/s41043-025-00882-7. J Health Popul Nutr. 2025. PMID: 40413548 Free PMC article. Review.
Cited by
-
How and when to manage respiratory infections out of hospital.Eur Respir Rev. 2022 Oct 19;31(166):220092. doi: 10.1183/16000617.0092-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36261157 Free PMC article. Review.
-
Risk factors for atopic diseases and recurrent respiratory tract infections in children.Pediatr Pulmonol. 2020 Nov;55(11):3168-3179. doi: 10.1002/ppul.25042. Epub 2020 Sep 15. Pediatr Pulmonol. 2020. PMID: 32841506 Free PMC article.
-
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).BMJ Open. 2024 Jan 10;14(1):e075948. doi: 10.1136/bmjopen-2023-075948. BMJ Open. 2024. PMID: 38199622 Free PMC article.
-
The Comparison of Metagenomic Next-Generation Sequencing with Conventional Microbiological Tests for Identification of Pathogens and Antibiotic Resistance Genes in Infectious Diseases.Infect Drug Resist. 2022 Oct 22;15:6115-6128. doi: 10.2147/IDR.S370964. eCollection 2022. Infect Drug Resist. 2022. PMID: 36277249 Free PMC article.
-
Holistic understanding of trimethoprim resistance in Streptococcus pneumoniae using an integrative approach of genome-wide association study, resistance reconstruction, and machine learning.mBio. 2024 Sep 11;15(9):e0136024. doi: 10.1128/mbio.01360-24. Epub 2024 Aug 9. mBio. 2024. PMID: 39120145 Free PMC article.
References
-
- UNICEF . United Nations International Children's Emergency Fund; New York: 2016. One is too many: ending child deaths from pneumonia and diarrhoea.
-
- WHO. UNICEF . World Health Organization; Geneva: 2013. End preventable deaths: global action plan for prevention and control of pneumonia and diarrhoea.
-
- UN Department of Economic and Social Affairs Transforming our world: the 2030 agenda for sustainable development. 2015. https://sustainabledevelopment.un.org/post2015/transformingourworld
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous